APP and Alzheimer disease: Dipotassium bisperoxo-(5-hydroxypyridine-2-carboxyl)-oxovanadate (bpv), a PTEN inhibitor, could decrease apoptosis and suppress the expression of ER stress related protein GRP78, CHOP, and Bax in APP/PS1 transgenic AD mice.